 |
Radiotherapy or radiation therapy
is a type of cancer treatment that uses radiation to kill cancer cells and
treat tumors. As a painless form of cancer treatment that allows patients
to retain quality of daily life, radiotherapy offers various advantages over
conventional surgical methods. Mitsubishi Heavy Industries (MHI) is now leveraging
its wide-ranging know-how as leading manufacturer of heavy machinery to develop,
produce and market highly-advanced machines for radiotherapy.
These efforts have culminated in the development of the MHI-TM2000. This
state-of-the-art radiotherapy machine accurately identifies the location of
tumors and meticulously directs radiation precisely where it is needed. In
this way, the MHI-TM2000 makes it easier to |
|
 |
perform highly accurate radiotherapy
treatment while minimizing damage to healthy cells. Because of this, the MHI-TM2000
is expected to contribute to new advances in cancer treatment.
The MHI-TM2000 has been approved by the U.S. Food and Drug Administration as
well as relevant authorities in Japan. It has also acquired certification in
Europe, that is, CE Marking.
MHI has already begun to deliver the MHI-TM2000 to medical institutions in
Japan and Europe. Overseas, the unit is being marketed as the Vero through
BrainLAB AG of Germany, an OEM* supply partner for the MHI-TM2000. The first
buyer outside of Japan was Belgium’s Brussels University Hospital, which
is one of Europe’s leading radiotherapy centers. In Japan, the MHI-TM2000
has been delivered to two hospitals and additional orders have been received
from two others.
* Original equipment manufacturer (OEM) |
 |
|
|
|
|
